Orchestra BioMed Inc.

NASDAQ: OBIO · Real-Time Price · USD
2.56
-0.10 (-3.76%)
At close: Aug 15, 2025, 3:59 PM
2.57
0.19%
After-hours: Aug 15, 2025, 07:58 PM EDT

Orchestra BioMed Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
2.64M 2.76M 3.53M -782K
Cost of Revenue
204K 186K 322K 199K
Gross Profit
2.43M 2.57M 3.21M -981K
Operating Income
-64.3M -51.51M -32.66M -21.8M
Interest Income
3.36M 3.85M 50K n/a
Pretax Income
-61.02M -49.12M -33.61M -23.01M
Net Income
-61.02M -49.12M -33.61M -23.01M
Selling & General & Admin
23.93M 20.26M 13.92M 7.93M
Research & Development
42.8M 33.82M 21.95M 12.89M
Other Expenses
n/a n/a n/a n/a
Operating Expenses
66.73M 54.08M 35.87M 20.82M
Interest Expense
n/a n/a n/a 927K
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
66.94M 54.27M 36.19M 21.02M
Income Tax Expense
n/a n/a n/a n/a
Shares Outstanding (Basic)
36.82M 33.23M 14.99M 20.45M
Shares Outstanding (Diluted)
36.82M 33.23M 14.99M 20.45M
EPS (Basic)
-1.66 -1.48 -2.24 -0.02
EPS (Diluted)
-1.66 -1.48 -2.24 -0.02
EBITDA
-64.3M -51.22M -32.44M -21.62M
EBIT
-64.3M -51.51M -32.66M -21.8M
Depreciation & Amortization
308K 287K 222K 181K